4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001390478-16-000111
Former Chief Financial Officer sold 126,875 shares at $2.18 ($276,588)
- Former Chief Financial Officer acquired 126,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dunlap Ryan Former Chief Financial Officer | 2016-06-01 | Option exercise | +31,250 | $1.75 | $54,688 | 49,952 | D |
| Dunlap Ryan Former Chief Financial Officer | 2016-06-01 | Option exercise | +65,625 | $1.85 | $121,406 | 115,577 | D |
| Dunlap Ryan Former Chief Financial Officer | 2016-06-01 | Option exercise | +30,000 | $1.71 | $51,300 | 145,577 | D |
| Dunlap Ryan Former Chief Financial Officer | 2016-06-01 | Sale | −126,875 | $2.18 | $276,588 | 18,702 | D |
| Derivatives | |||||||
| Dunlap Ryan Former Chief Financial Officer | 2016-06-01 | Option exercise · Stock Option | −31,250 | 95,625 | D | ||
| Dunlap Ryan Former Chief Financial Officer | 2016-06-01 | Option exercise · Stock Option | −65,625 | 30,000 | D | ||
| Dunlap Ryan Former Chief Financial Officer | 2016-06-01 | Option exercise · Stock Option | −30,000 | 0 | D | ||
| Open-market sales · 126,875 sh · avg $2.18 · $276,588 | |||||||
Loading xslF345X03/primary_doc.xml…